Online ISSN: 2515-8260
-
EFFECT OF CAFFEINE INTAKE ON CARDIOPULMONARY EFFICIENCY TEST
Volume 11 (2024) | Issue 5
-
SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH): EXPERIENCE FROM A TERTIARY CARE HOSPITAL.
Volume 11 (2024) | Issue 5
-
“BIOMARKERS IN THE PREDICTION OF PROGNOSIS IN TRAUMATIC HEAD INJURY PATIENTS AT OUR TERTIARY CARE HOSPITAL”: A PROSPECTIVE FOLLOW-UP STUDY
Volume 11 (2024) | Issue 5
-
LAPAROSCOPIC GUIDED (VS) ULTRASOUND GUIDED TAP BLOCK (VS) NO TAP BLOCK IN LAPAROSCOPIC CHOLECYSTECTOMY A RANDOMISED DOUBLE BLINDED CONTROLLED TRIAL
Volume 11 (2024) | Issue 5
-
ROLE OF MORPHOMETRY IN DIAGNOSING PREMALIGNANT AND MALIGNANT LESIONS IN LIQUID BASED CYTOLOGY CERVICAL SMEAR(PAP SMEAR)
Volume 11 (2024) | Issue 4
Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing lower abdominal surgery
Main Article Content
Abstract
Background: The goal of PONV management is to reduce or eliminate PONV and discomfort with minimum side effects. 5-HT antagonists work by blocking one of the pathways that lead to vomiting. Ondansetron is the most commonly used drug for this purpose. Ramosetron has a higher affinity for the 5-HT3 receptor than the older 5-HT3 antagonists, with an optimal dose of 0.6 mg and maintains its effects over two days.
